newsfilter
← Latest News
PR Newswire·

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

VANCOUVER, BC, Oct. 28, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce the signing of a non-bi